Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bai Liu

Showing results (101-110 of 207) with videos related to

Pageof 21
Sort By:
Clinical Drug Investigation|October 14, 2017
Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in ChinaNa Li, Bin Zheng, Hong-Fu Cai, et al.
Frontiers in Oncology|January 24, 2022
An 11-Gene Signature Based on Treatment Responsiveness Predicts Radiation Therapy Survival Benefit Among Breast Cancer PatientsJunjie Shen, Derui Yan, Lu Bai, et al.
Journal of Molecular Neuroscience : MN|June 6, 2015
Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor BarrierZhen Li, Xiao-Bai Liu, Yun-Hui Liu, et al.
Discover Oncology|March 29, 2025
ERCC3 serves as a prognostic biomarker for hepatocellular carcinoma and positively regulates cell proliferation and migrationChen Yang, Jiahui Du, Xiuqin Qiu, et al.
American Journal of Cancer Research|April 12, 2022
Integration of immune and hypoxia gene signatures improves the prediction of radiosensitivity in breast cancerDerui Yan, Shang Cai, Lu Bai, et al.
Journal of Visualized Experiments : Jove|November 3, 2025
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 InhibitorsJiani Ge, Yunfan Sun, Jingsheng Hua, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 6, 2022
Comprehensive analysis of ERCC3 prognosis value and ceRNA network in AMLXiebing Bao, Yao Chen, Xiao Lou, et al.
Molecular Medicine Reports|January 25, 2020
Class C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cellsChun Rao, Yi-Ran Ni, Yan-Min Zhao, et al.
Natural Product Research|October 26, 2017
A new insecticidal havanensin-type limonoid from the roots of <i>Trichilia sinensis</i> BentvShou-Bai Liu, Hui-Qin Chen, Gang Feng, et al.
Natural Product Research|January 18, 2020
A new ergostane derivative from the leaves of <i>Heynea trijuga</i> RoxburghShou-Bai Liu, Zheng Cui, Hui-Qin Chen, et al.
Pageof 21

Showing results (101-110 of 207) with videos related to

Sort By:
Pageof 21
Clinical Drug Investigation|October 14, 2017
Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in ChinaNa Li, Bin Zheng, Hong-Fu Cai, et al.
Frontiers in Oncology|January 24, 2022
An 11-Gene Signature Based on Treatment Responsiveness Predicts Radiation Therapy Survival Benefit Among Breast Cancer PatientsJunjie Shen, Derui Yan, Lu Bai, et al.
Journal of Molecular Neuroscience : MN|June 6, 2015
Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor BarrierZhen Li, Xiao-Bai Liu, Yun-Hui Liu, et al.
Discover Oncology|March 29, 2025
ERCC3 serves as a prognostic biomarker for hepatocellular carcinoma and positively regulates cell proliferation and migrationChen Yang, Jiahui Du, Xiuqin Qiu, et al.
American Journal of Cancer Research|April 12, 2022
Integration of immune and hypoxia gene signatures improves the prediction of radiosensitivity in breast cancerDerui Yan, Shang Cai, Lu Bai, et al.
Journal of Visualized Experiments : Jove|November 3, 2025
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 InhibitorsJiani Ge, Yunfan Sun, Jingsheng Hua, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 6, 2022
Comprehensive analysis of ERCC3 prognosis value and ceRNA network in AMLXiebing Bao, Yao Chen, Xiao Lou, et al.
Molecular Medicine Reports|January 25, 2020
Class C1 decoy oligodeoxynucleotide inhibits profibrotic genes expression in rat hepatic stellate cellsChun Rao, Yi-Ran Ni, Yan-Min Zhao, et al.
Natural Product Research|October 26, 2017
A new insecticidal havanensin-type limonoid from the roots of <i>Trichilia sinensis</i> BentvShou-Bai Liu, Hui-Qin Chen, Gang Feng, et al.
Natural Product Research|January 18, 2020
A new ergostane derivative from the leaves of <i>Heynea trijuga</i> RoxburghShou-Bai Liu, Zheng Cui, Hui-Qin Chen, et al.
Pageof 21